Development of an oral treatment with the PPAR-γ-acting cannabinoid VCE-003.2 against the inflammation-driven neuronal deterioration in experimental Parkinson’s disease

1. Burgaz, S.
2. García, C.
3. Gómez-Cañas, M.
4. Muñoz, E.
5. Fernández-Ruiz, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/MOLECULES24152702 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus